Influence of melatonin receptor signalling on parameters involved in blood glucose regulation

Journal of Pineal Research

Volumn 56, Issue 1, 2014, Pages 82-96

  Bazwinsky Wutschke, Ivonne ^a   Bieseke, Lars ^a   Mühlbauer, Eckhard ^b   Peschke, Elmar ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b Saxon Academy of Sciences   (Germany)

Author keywords

glucose transporter; INS 1; melatonin receptor knockout mouse; pancreatic islet hormones

Indexed keywords

GENOMIC DNA; GLUCOSE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 2; INSULIN; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; MELATONIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; FEMALE; GENOTYPE; GLUCOSE BLOOD LEVEL; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULINOMA; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET; PANCREAS ISLET BETA CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WILD TYPE;

GLUCOSE TRANSPORTER; INS-1; MELATONIN RECEPTOR KNOCKOUT MOUSE; PANCREATIC ISLET HORMONES;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CELL LINE, TUMOR; FEMALE; GLUCAGON; GLUCOSE TRANSPORTER TYPE 1; INSULIN; MALE; MELATONIN; MICE; MICE, KNOCKOUT; ORGAN SPECIFICITY; RECEPTOR, MELATONIN, MT1; RECEPTOR, MELATONIN, MT2; RNA, MESSENGER; SOMATOSTATIN;

EID: 84890129569     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12100     Document Type: Article

References (69)

1. Hoyos M, Guerrero JM, Perez-Cano R, et al. Serum cholesterol and lipid peroxidation are decreased by melatonin in diet-induced hypercholesterolemic rats. J Pineal Res 2000; 28: 150-155.
2. Fabis M, Pruszynska E, Mackowiak P,. In vivo and in situ action of melatonin on insulin secretion and some metabolic implications in the rat. Pancreas 2002; 25: 166-169.
3. Peschke E,. Melatonin, endocrine pancreas and diabetes. J Pineal Res 2008; 44: 26-40.
4. Peschke E, Mühlbauer E,. New evidence for a role of melatonin in glucose regulation. Best Pract Res Clin Endocrinol Metab 2010; 24: 829-841.
5. Peschke E, Bähr I, Mühlbauer E,. Melatonin and pancreatic islets: interrelationships between melatonin, insulin and glucagon. Int J Mol Sci 2013; 14: 6981-7015.
6. Nishida S, Sato R, Murai I, et al. Effect of pinealectomy on plasma levels of insulin and leptin and on hepatic lipids in type 2 diabetic rats. J Pineal Res 2003; 35: 251-256.
7. Borges-Silva CN, Alonso-Vale MI, Franzoi-De-moraes SM, et al. Pinealectomy impair adipose tissue adaptability to exercise in rats. J Pineal Res 2005; 38: 278-283.
8. Venegas C, Garcia JA, Escames G, et al. Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations. J Pineal Res 2012; 52: 217-227.
9. Zanquetta MM, Seraphim PM, Sumida DH, et al. Calorie restriction reduces pinealectomy-induced insulin resistance by improving GLUT4 gene expression and its translocation to the plasma membrane. J Pineal Res 2003; 35: 141-148.
10. Ghosh G, De K, Maity S, et al. Melatonin protects against oxidative damage and restores expression of GLUT4 gene in the hyperthyroid rat heart. J Pineal Res 2007; 42: 71-82.
11. Huang S, Czech MP,. The GLUT4 glucose transporter. Cell Metab 2007; 5: 237-252.
12. Mueckler M, Thorens B,. The SLC2 (GLUT) family of membrane transporters. Mol Aspects Med 2013; 34: 121-138.
13. Thorens B, Flier JS, Lodish HF, et al. Differential regulation of two glucose transporters in rat liver by fasting and refeeding and by diabetes and insulin treatment. Diabetes 1990; 39: 712-719.
14. Thorens B, Sarkar HK, Kaback HR, et al. Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and beta-pancreatic islet cells. Cell 1988; 55: 281-290.
15. de Vos A, Heimberg H, Quartier E, et al. Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J Clin Invest 1995; 96: 2489-2495.
16. Srivastava RK, Krishna A,. Melatonin modulates glucose homeostasis during winter dormancy in a vespertilionid bat, Scotophilus heathi. Comp Biochem Physiol A Mol Integr Physiol 2010; 155: 392-400.
17. Peschke E, Fauteck JD, Musshoff U, et al. Evidence for a melatonin receptor within pancreatic islets of neonate rats: functional, autoradiographic, and molecular investigations. J Pineal Res 2000; 28: 156-164.
18. Picinato MC, Haber EP, Cipolla-Neto J, et al. Melatonin inhibits insulin secretion and decreases PKA levels without interfering with glucose metabolism in rat pancreatic islets. J Pineal Res 2002; 33: 156-160.
19. Peschke E, Mühlbauer E, Musshoff U, et al. Receptor (MT(1)) mediated influence of melatonin on cAMP concentration and insulin secretion of rat insulinoma cells INS-1. J Pineal Res 2002; 33: 63-71.
20. 2-melatonin receptor, in the rat pancreas, islet and beta-cell. J Pineal Res 2007; 42: 105-106.
21. Peschke E, Stumpf I, Bazwinsky I, et al. Melatonin and type 2 diabetes-a possible link? J Pineal Res 2007; 42: 350-358.
22. Poon AM, Choy EH, Pang SF,. Modulation of blood glucose by melatonin: a direct action on melatonin receptors in mouse hepatocytes. Biol Signals Recept 2001; 10: 367-379.
23. Mühlbauer E, Gross E, Labucay K, et al. Loss of melatonin signalling and its impact on circadian rhythms in mouse organs regulating blood glucose. Eur J Pharmacol 2009; 606: 61-71.
24. Venegas C, Garcia JA, Doerrier C, et al. Analysis of the daily changes of melatonin receptors in the rat liver. J Pineal Res 2013; 54: 313-321.
25. Kemp DM, Ubeda M, Habener JF,. Identification and functional characterization of melatonin Mel 1a receptors in pancreatic beta cells: potential role in incretin-mediated cell function by sensitization of cAMP signaling. Mol Cell Endocrinol 2002; 191: 157-166.
26. 2+ release from INS1 insulinoma cells. J Pineal Res 2005; 39: 316-323.
27. Peschke E, Bach AG, Mühlbauer E,. Parallel signaling pathways of melatonin in the pancreatic beta-cell. J Pineal Res 2006; 40: 184-191.
28. Peschke E, Frese T, Chankiewitz E, et al. Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status. J Pineal Res 2006; 40: 135-143.
29. 2. J Pineal Res 2011; 51: 361-372.
30. Liu C, Weaver DR, Jin X, et al. Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 1997; 19: 91-102.
31. Jin X, von Gall C, Pieschl RL, et al. Targeted disruption of the mouse Mel(1b) melatonin receptor. Mol Cell Biol 2003; 23: 1054-1060.
32. Bazwinsky-Wutschke I, Mühlbauer E, Wolgast S, et al. Transcripts of calcium/calmodulin-dependent kinases are changed after forskolin- or IBMX-induced insulin secretion due to melatonin treatment of rat insulinoma beta-cells (INS-1). Horm Metab Res 2009; 41: 805-813.
33. Mühlbauer E, Wolgast S, Finckh U, et al. Indication of circadian oscillations in the rat pancreas. FEBS Lett 2004; 564: 91-96.
34. Livak KJ, Schmittgen TD,. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Methods 2001; 25: 402-408.
35. Pfaffl MW,. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45.
36. Frese T, Bazwinsky I, Mühlbauer E, et al. Circadian and age-dependent expression patterns of GLUT2 and glucokinase in the pancreatic beta-cell of diabetic and nondiabetic rats. Horm Metab Res 2007; 39: 567-574.
37. Bazwinsky-Wutschke I, Wolgast S, Mühlbauer E, et al. Distribution patterns of calcium-binding proteins in pancreatic tissue of nondiabetic as well as type 2 diabetic rats and in rat insulinoma beta-cells (INS-1). Histochem Cell Biol 2010; 134: 115-127.
38. Welp A, Manz B, Peschke E,. Development and validation of a high throughput direct radioimmunoassay for the quantitative determination of serum and plasma melatonin (N-acetyl-5-methoxytryptamine) in mice. J Immunol Method 2010; 358: 1-8.
39. Peschke E, Peschke D, Hammer T, et al. Influence of melatonin and serotonin on glucose-stimulated insulin release from perifused rat pancreatic islets in vitro. J Pineal Res 1997; 23: 156-163.
40. Peschke E, Schucht H, Mühlbauer E,. Long-term enteral administration of melatonin reduces plasma insulin and increases expression of pineal insulin receptors in both Wistar and type 2-diabetic Goto-Kakizaki rats. J Pineal Res 2010; 49: 373-381.
41. Tan DX, Manchester LC, Fuentes-Broto L, et al. Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity. Obesity Rev 2011; 12: 167-188.
42. Brydon L, Petit L, Delagrange P, et al. Functional expression of MT2 (Mel1b) melatonin receptors in human PAZ6 adipocytes. Endocrinology 2001; 142: 4264-4271.
43. Alonso-Vale MI, Anhe GF, Borges-Silva CD, et al. Pinealectomy alters adipose tissue adaptability to fasting in rats. Metabolism 2004; 53: 500-506.
44. Abel ED, Peroni O, Kim JK, et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 2001; 409: 729-733.
45. Sallinen P, Saarela S, Ilves M, et al. The expression of MT1 and MT2 melatonin receptor mRNA in several rat tissues. Life Sci 2005; 76: 1123-1134.
46. Contreras-Alcantara S, Baba K, Tosini G,. Removal of melatonin receptor type 1 induces insulin resistance in the mouse. Obesity (Silver Spring) 2010; 18: 1861-1863.
47. Vanecek J,. Cellular mechanisms of melatonin action. Physiol Rev 1998; 78: 687-721.
48. Naji L, Carrillo-Vico A, Guerrero JM, et al. Expression of membrane and nuclear melatonin receptors in mouse peripheral organs. Life Sci 2004; 74: 2227-2236.
49. Slominski RM, Reiter RJ, Schlabritz-Loutsevitch N, et al. Melatonin membrane receptors in peripheral tissues: distribution and functions. Mol Cell Endocrinol 2012; 351: 152-166.
50. 1 receptors in rat insulinoma cells (INS-1) and mouse pancreatic islets. J Pineal Res 2012; 52: 446-459.
51. Bazwinsky-Wutschke I, Wolgast S, Mühlbauer E, et al. Phosphorylation of cyclic AMP-response element-binding protein (CREB) is influenced by melatonin treatment in pancreatic rat insulinoma β-cells (INS-1). J Pineal Res 2012; 53: 344-357.
52. Mayr B, Montminy M,. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2001; 2: 599-609.
53. Sander M, German MS,. The beta cell transcription factors and development of the pancreas. J Mol Med (Berl) 1997; 75: 327-340.
54. Fürstenau U, Schwaninger M, Blume R, et al. Characterization of a novel calcium response element in the glucagon gene. J Biol Chem 1999; 274: 5851-5860.
55. Oetjen E, Grapentin D, Blume R, et al. Regulation of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus at concentrations that inhibit calcineurin activity and involving the transcription factor CREB. Naunyn Schmiedebergs Arch Pharmacol 2003; 367: 227-236.
56. Sheynzon P, Korf HW,. Targeted deletions of Mel1a and Mel1b melatonin receptors affect pCREB levels in lactotroph and pars intermedia cells of mice. Neurosci Let 2006; 407: 48-52.
57. Bähr I, Mühlbauer E, Schucht H, et al. Melatonin stimulates glucagon secretion in vitro and in vivo. J Pineal Res 2011; 50: 336-344.
58. Tal M, Liang Y, Najafi H, et al. Expression and function of GLUT-1 and GLUT-2 glucose transporter isoforms in cells of cultured rat pancreatic islets. J Biol Chem 1992; 267: 17241-17247.
59. +ATP channels in human pancreatic beta cells early in development. Diabetologia 2007; 50: 1000-1005.
60. McCulloch LJ, Van De Bunt M, Braun M, et al. GLUT2 (SLC2A2) is not the principal glucose transporter in human pancreatic beta cells: implications for understanding genetic association signals at this locus. Mol Genet Metab 2011; 104: 648-653.
61. Vinals F, Ferre J, Fandos C, et al. Cyclic adenosine 3′,5′- monophosphate regulates GLUT4 and GLUT1 glucose transporter expression and stimulates transcriptional activity of the GLUT1 promoter in muscle cells. Endocrinology 1997; 138: 2521-2529.
62. Kim MO, Lee YJ, Park JH, et al. PKA and cAMP stimulate proliferation of mouse embryonic stem cells by elevating GLUT1 expression mediated by the NF-κB and CREB/CBP signaling pathways. Biochim Biophys Acta 2012; 1820: 1636-1646.
63. Kao YS, Fong JC,. A novel cross-talk between endothelin-1 and cyclic AMP signaling pathways in the regulation of GLUT1 transcription in 3T3-L1 adipocytes. Cell Signal 2011; 23: 901-910.
64. Lyssenko V, Nagorny CL, Erdos MR, et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet 2009; 41: 82-88.
65. Prokopenko I, Langenberg C, Florez JC, et al. Variants in MTNR1B influence fasting glucose levels. Nat Genet 2009; 41: 77-81.
66. Bouatia-Naji N, Bonnefond A, Cavalcanti-Proenca C, et al. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet 2009; 41: 89-94.
67. Staiger H, Machicao F, Schäfer SA, et al. Polymorphisms within the novel type 2 diabetes risk locus MTNR1B determine beta-cell function. PLoS ONE 2008; 3: e3962.
68. Li X, Gu Q, Chen H, et al. A common polymorphism rs3781637 in MTNR1B is associated with type 2 diabetes and lipids levels in Han Chinese individuals. Cardiovasc Diabetol 2011; 10: 27.
69. Li C, Shi Y, You L, et al. Melatonin receptor 1A gene polymorphism associated with polycystic ovary syndrome. Gynecol Obstet Invest 2011; 72: 130-134.